Double-blind study of a psychotropic-anticholinergic drug in gastric disorders.
D001561:Benzilates / Q000627:therapeutic use*; D002707:Chlordiazepoxide / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010276:Parasympatholytics / Q000627:therapeutic use*; D010919:Placebos; D011602:Psychophysiologic Disorders / Q000188:drug therapy*; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*; D011812:Quinuclidines / Q000627:therapeutic use*
D001561:Benzilates; D010276:Parasympatholytics; D010919:Placebos; D000644:Quaternary Ammonium Compounds; D011812:Quinuclidines; D002707:Chlordiazepoxide